ethos capital investor presentation › wp-content › uploads › 2018 › 03 › ec...strategy...
TRANSCRIPT
E T H O S C A P I TA L
I N V E S T O R P R E S E N TAT I O N
March 2018
© Ethos | 2
2
General market outlook
Ethos Capital market update
Outlook for Ethos Capital
Invested Capital was 39% of NAV as at December 2017
MTN, Kevro closed in July and October, Primedia in December
Offers in on businesses with a total investment for Ethos Capital of c.R400m
Strong opportunity pipeline for Fund VII
Mid Market Fund c.44% invested with good execution visibility on new deals
Healthcare platform investment program has begun (one deal signed, one in execution)
Mezzanine Fund pipeline is strong, investment program to commence in April 2018
Outlook for market conditions and business / consumer sentiment turned positive post December
Tough 2H2017 for most Portfolio Companies, sentiment will take time to impact profitability
Asset selection and pricing remains key
Focus on cost management and strategic growth levers in Portfolio Companies
Strong investment pipeline across the Funds
Portfolio well placed to benefit from an improved macroeconomic outlook
© Ethos | 3
Portfolio Company diversification
Note: size of bubble representative of Ethos
Capital’s economic interest in the Portfolio Companies
© Ethos | 4
6,66 6,47
4,10 4,29
8,49
31 Dec 2017 Proforma Share price
Cash Invested Capital Share price
10,37
10,76
0,29
0,16 0,03
0,06 0,03
30 June 2017 TemporaryInvestment
return
InvestedPortfolio
return
Sharebuybacks
Expenses & tax Ethos fees 31 December2017
1% 1% 1% 1% 1%
5%
8%9% 9%
14%
22%
28%
4
NAV overview (NAVPS)1
Proforma Invested NAV contribution High level overview of pipeline transactions (Rm)3 4
Portfolio overview
Portfolio composition per share (NAVPS)2
R10.76
39% 41%
R764m
NAV
% of NAV% of NAV
Invested NAV
Discount to NAV
21%
730
1 118
102
286
Current Invested NAV Signed transactions Exclusive negotiations Proforma Invested NAV
Direct InvestmentsMid Market Fund InvestmentsFund VI Investments
© Ethos | 5
21%
41%
Discount to NAV Discount to peer group
4,9x 4,4x5,6x 5,1x
8,5x
5,3x 5,7x
7,6x
2,0x2,4x
2,2x
1,7x
2,7x
4,9x4,8x 1,5x
6.9x 6.8x
7.8x
6.8x
11.2x
10.2x10.5x
9.1x
Ethos Capital Directs Fund VI EMMF Brait North America Western Europe RoW
Equity Debt EV / EBITDA
0,5%
0,9%
0,6%
0,7%
2,4%
10,1%
10,8%
11,7%
28,7%
33,6%
BevCo
RTT
Neopak
Eaton Towers
Waco
Twinsaver
Autozone
Eazi Access
Kevro
Primedia
6,9x
2,0x
-
1,0x
2,0x
3,0x
4,0x
5,0x
6,0x
7,0x
8,0x
EV / EBITDA Net debt / EBITDA
5
Ethos Capital valuation and Portfolio Companies’ average discount to
peer group companies1
Weighted average EV / EBITDA – comparisons with SA investment companies and global funds 3
Ethos Capital NAV analysis
Portfolio EBITDA contribution (excluding MTN Zakhele Futhi)
Note: Brait valuation multiple based on weighted average of Virgin Active, Premier and Iceland Foods
11.7x
Peer group companies’ weighted average EV / EBITDA
2
R129m
Attributable EBITDA
© Ethos | 6
Mezzanine Fund
Mid Market Fund
Healthcare Platform
Buyout Fund (Fund VI and Fund VII)
4
6
Ethos Capital fund commitments2
Ethos funds - risk reward frontier
Ethos fund evolution
Risk reward frontier – fund view
3
1
Mezzanine Fund
Buyout Fund
Mid Market Fund
AI Fund
Healthcare Platform
Return
Risk
Target IRR
15-17%
Target IRR
18-22%
Target IRR
22-25%
Target IRR
25-28%
Target IRR
Base IRR +5%
Monolineprivate equity
business
Alternative asset
management business
1984 Fund I
US$101m
1992 Fund II
US$34m
1996 Fund III
US$172m
1998 Fund IV
US$358m
2006 Fund V
US$747m
2018 AI Fund
US$75m
2018 Fund VII
US$800m
2017
Healthcare
US$150m
2017
Mezzanine
US$150m
2016 Mid Market
US$150m2012 Fund VI
US$805m
Commitment
Fund VI US$10m (1.4% of total fund)
Fund VII R1.25bn first close commitment
Drawn down
Fund VI US$8.3m (83%), Fund VII R0m
Commitment
R900m (c.49% of total fund)
Drawn down
R362m (40%) – as at December 2017
R396m (44%) - current
Commitment
R250m first close commitment
R320m final commitment
Drawn down
R0m
Commitment
R250m first close commitment
Drawn down
R0m
© Ethos | 7
3,1x2,5x
3,8x4,5x 4,7x 4,9x
7,2x1,7x 2,6x
3,2x2,7x
4,8x 4,3x
1,7x
Fund III Fund IV Fund V Fund VI NorthAmerica
WesternEurope
Rest of world
Debt Equity
(Entry EBITDA multiple)
8.9x
7.2x7.0x
5.1x4.8x
(Average - last five years)
9.5x9.2x
53 53
23
3
4
49
18
31 Dec 16 31 Dec 16 31 Dec 17 31 Dec 17
Opening Invested Capital New investments Realised growth
NAV growth Undrawn commitments
7
Current Fund performance by asset vintage
Buyout funds in-cost analysis and funding structure2
Buyout Fund VI
Ethos Capital commitments and fund performance (Rm)
Fund parameters
4
1
3
Fund size
Final close in 2012
US$805 million fund size
Deal specifics
Companies with an Enterprise Value of R1.5-8.0 billion
Equity cheque size of R0.4-1.0 billion per investment
Country focus
South Africa with a 20% carve out for investments in Sub Saharan Africa
Sector focus
All sectors excluding deep level mining, real estate and the “sin” industries
Prudential limits
Maximum investment of 15% of the committed capital per transaction
Type of transaction
Buyouts, growth capital for strong highly cashflow generative businesses
Majority control positions (either sole or joint control) or strong minority protections
Fund Size – US$805m
Vintage – 2012
Strategy – large buyouts in SA and rest of SSA
14% uninvested
© Ethos | 8
292 292
70
42 255
532
31 Dec 16 31 Dec 16 31 Dec 17 31 Dec 17
Opening Invested Capital New investments Realised growth
NAV growth Undrawn commitments
6,8x
1,7x
EV / EBITDA Net debt / EBITDA
Mid Market LBO Buyout Fund co-investmentFacilitated & secondary BEE
and Special Opportunities
IRR TARGET >25% >25% 25%-35%
INVESTMENT SIZE
GUIDELINESR100-350m R100-350m R100-350m
TARGETS
High growth potential
companies that are often not
optimally capitalised
Buyout Fund investments that
require a BEE shareholder
High risk-adjusted returns in
market leading businesses
INVESTMENT STRATEGY
Leverage Ethos Value Add,
ESG and operational
transformation skills
Leverage Fund VI & VII
investment team
Facilitated & secondary BEE
deals, mezzanine funding/
share cover funding for BEE
DEAL TYPELead shareholder / significant
influenceEthos significant influence
Significant influence and/or self
liquidating instruments
ALLOCATION >50% of capital deployed Balance of capital deployed
8
Current Fund performance by asset vintage
Valuation of the EMMF portfolio2
Mid Market Fund I
Ethos Capital commitments and fund performance (Rm)
Fund parameters
4
1
3
Fund Size – R2.0bn
Vintage – 2016
Strategy – mid-size buyout transactions in SA (BEE fund)
60% uninvested
© Ethos | 9
9
Ethos Mezzanine Fund target return and product offering
Ethos Capital commitments and fund pipeline2
Mezzanine Fund
Fund parameters1
4
Stage
Established middle- and later-stage business, proven FCF generation-capability, CSF / competitive advantages, management, and shareholders of reference
Growth, expansion, acquisition and replacement finance
EBITDA ≥ US$3m
EV ≥ US$20m
Deal specifics
Mezzanine tranches of c.US$5-30m
Single investment limits
15%
Sector focus
Generalist with focus on financial institutions / insurance; consumer; professional services; industrial goods and materials; TMT; travel and tourism; healthcare
Sector limits: 25%
Country limits
SSA focussed fund with 30% per single country
Base case Scenario Scenario Scenario
Business to be
capitalised
Capital layers In the absence of
mezzanine funding
Mezzanine lender #1 Mezzanine lender #2 Mezzanine lender #3
Target capital
requirement US$100m
Senior secured debt 40% 40% 40% 40%
Mezzanine debt 0% 10% 20% 30%
Shareholders’ equity 60% 50% 40% 30%
Type of mezzanine No mezzanine More debt like Hybrid More equity-like
Instrument return featuresPredominantly contracted
returns
Mixture of contracted
returns and equity kickers
Predominantly equity
kicker-linked returns
Targeted returns (US$) >10% p.a. c.15-18% p.a. >20% p.a.
Fund Size – US$150m
Vintage – first close Q2 2018
Strategy – mezzanine growth capital in SSA and SA
250 320
1 440
1 800
EthosCapital
EthosCapital
Total Total
First close Final close
18%
Transactions
2 signed term sheets
Total funding required US$30m
Ethos Capital funding c.US$6.0m
Deal specifics
Mezzanine debt with equity upside
Timeline
Q2 2018
Geography
SSA
© Ethos | 10
360 500
621 771
958
1 191
1 452
1 734 1 893
2 173
2 544
2 912
3 337
3 611
-
500
1 000
1 500
2 000
2 500
3 000
3 500
4 000
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Initial Phase
21%
11%
15%
RONA33%
46%
PE Phase
Listed Phase
EBITDA CAGR
26-75%
10
The investment thesis
Ethos Healthcare Vehicle
Key differentiators Platform structure
Team’s track record at Life Healthcare (EBITDA growth)
1 32
4 Ethos Capital commitments and platform pipeline5
30+ year track record in PE in SSA
Proven track record in operating, growing and listing one of SSA’s largest private hospital groups
Ability to optimise / extract operational efficiencies
Proven track record in acquisition led growth
Ability to attract aligned co-investors and manage exits
Unique structure
Focus on health service providers including:
• most common healthcare needs and specialties
• outpatient and primary care
• tiered “hub and spoke” network of hospitals and clinics
Also complementary adjacencies including specialty chains
focused on diagnosis (e.g. imaging, labs), common
healthcare needs (e.g. eye care, fertility) and MedTech
Geographic focus areas - South Africa & sub-Saharan
Africa (SSA)
Matching the need for growth capital and operational
expertise through partnershipsPlatform
investors
EHF
PathologyEye CareHospital
Group
Bolt On 1
Bolt On 2
26-51% 26-75%
26-75%
MedTech
Fund Size – R2.0 to 3.0bn
Vintage – First close Q2 2018
Strategy – investment into healthcare companies in SA and SSA
Principals – Michael Flemming, Jonathan Lowick
250
1 200
Ethos Capital Total
First close
21%
Transactions
1 transaction completed (subject to regulatory approval)
1 transaction in final negotiations
Total funding required R460m
Ethos Capital funding c.R100m
Deal specifics
MedTech platform build
Regional hospital group
Timeline
Q2 2018
Geography
SA
© Ethos | 11
11
The investment thesis
Ethos AI Fund
Sector focus Activities that AI will impact
Applying the AI investment lens
Digitisation and big data
Access to exceptional analytics resources
Access to largest PE firm’s origination platform
Fund commitment and alignment
Focus on targets with multiplicative value chain
Implementing disciplined strategic analytics program
1 32
4
Selected Financial Services
Consumer Retail
Healthcare
Medtech
Media / Digital
Logistics
High Low
Susceptib
ility
to v
alu
echain
im
pro
vem
ent
Sophistication of analytics
Low High
Siz
e o
f data
Data driven decisioning
Small Big
Exponentia
l te
chnolo
gy &
M
acro
-tre
nds
Size and sustainability of moat
Value chain &
sophistication lensData and decisioning lens
Trends and moat
lens
Investment case AI uplift estimates – prioritisation and decision-making framework5
AI Value Chain
Opportunity
#1 - Δ%
#2 - Δ%
#3 - Δ%
#4 - Δ%
#5 - Δ%
#6 - Δ%
Technical difficulty
Estimates
Change Management
overhead
Estimates
Incentives?
Estimates
Power base?
Estimates
Cost & Resourcing Required
Estimates
Availability of Resources
Estimates
Executive Buy-in
Estimates
Risk Adjusted Priority
Intrinsic Value Lift adjusted for risk
Fund Size – R750 to 1,000m
Vintage – Not launched yet
Strategy – co-investment alongside Ethos funds in business
which can benefit from implementation of AI technologies
Principals – Roger Grobler, Nic Kohler
Customer engagement
Marketing
Product
Operations
Finance
HR
Risk
Technology
Cybersecurity
Supply chain
© Ethos | 12
730
1 118
102
286
Current Invested NAV Signed transactions Exclusivenegotiations
Proforma InvestedNAV
345 345
353 3
46
1 449
1 184
304 558
31 Dec 16 31 Dec 16 31 Dec 17 31 Dec 17
Opening Invested Capital New investmentsRealised growth NAV growthCashUndrawn commitments
12
Overview of the investment pipeline (Ethos Capital investment in Rm)1
Ethos Capital Fund and Direct Investment commitments Proforma commitments and available funding capacity3 4
Investment pipeline and liquidity analysis
Proforma Invested NAV2
-
20
40
60
80
100
120
Consumerservices
ICT Industrialservices
Hospital MedTech FMCG FMCG
Mid Market Fund Healthcare Platform Mezzanine Fund
Fund VI Direct
16.9% Gross Invested NAV Growth 15.9% Net Invested NAV Growth
Note : Net new commitments estimated at 90% of commitments (Fund VII, Healthcare platform, Mezzanine Fund)
1 184
1 771
1 213
1 485
587 558
Cash at Dec 2017 Bank facility Investmentcapacity
Undrawncommitments
Unutilisedcapacity
Net newcommitments